GLP-1 Awareness Hits 92%, but Adoption Lags Due to Access Barriers — Reach3 Insights

Event summary

92% of Americans are now aware of GLP-1 medications, per Reach3 Insights' 'Beyond Weight Loss' study.
38% of non-users express interest in trying GLP-1s, despite only 13% currently using them.
65% of current users take GLP-1s for weight loss, while 57% report eating smaller portions.
25% of users are eating out less often, choosing more low/no sugar beverages.
Study surveyed 1,043 U.S. adults using conversational research techniques.

The big picture

The study highlights GLP-1s' growing influence beyond weight loss, affecting consumer food relationships and routines. With 92% awareness but only 13% adoption, the gap suggests significant unmet demand. This trend has implications for healthcare, food and beverage, and other industries as consumer behaviors shift. Reach3 Insights' research underscores the need for brands to understand these evolving motivations and their business impact.

What we're watching

Access Barriers: Whether cost, insurance coverage, and access issues will continue limiting GLP-1 adoption despite high interest.
Behavioral Shifts: How reduced cravings and eating out less will impact food and beverage demand across categories.
Pill Formats: The pace at which new pill formats from leading pharmaceutical companies may accelerate GLP-1 adoption.